Fontan-associated liver disease - PubMed (original) (raw)

Review

. 2022 May;75(5):1300-1321.

doi: 10.1002/hep.32406. Epub 2022 Mar 15.

Affiliations

• PMID: 35179797
• DOI: 10.1002/hep.32406

Review

Fontan-associated liver disease

Moira B Hilscher et al. Hepatology. 2022 May.

No abstract available

PubMed Disclaimer

Similar articles

• [Fontan-associated liver disease current status and transplantation consideration].
  Liu X, Tu JZC, Teng Y, Chen JM. Liu X, et al. Zhonghua Gan Zang Bing Za Zhi. 2023 Jan 20;31(1):109-112. doi: 10.3760/cma.j.cn501113-20210612-00277. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 36948859 Chinese.
• Surveillance of Fontan-associated liver disease: current standards and a proposal from the European Society of Paediatric Radiology Abdominal Task Force.
  Perucca G, de Lange C, Franchi-Abella S, Napolitano M, Riccabona M, Ključevšek D, Toso S, Herrmann J, Stafrace S, Darge K, Damasio MB, Bruno C, Woźniak MM, Lobo L, Ibe D, Smets AM, Petit P, Ording Müller LS. Perucca G, et al. Pediatr Radiol. 2021 Dec;51(13):2598-2606. doi: 10.1007/s00247-021-05173-x. Epub 2021 Oct 15. Pediatr Radiol. 2021. PMID: 34654967 Free PMC article.
• Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
  Kuwabara M, Niwa K, Toyoda T, Shirai T, Tateno S, Ohuchi H, Tanaka Y, Ichida F, Fujisawa T, Akagi T, Mori Y; Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery. Kuwabara M, et al. Circ J. 2018 Mar 23;82(4):1155-1160. doi: 10.1253/circj.CJ-17-1053. Epub 2018 Feb 14. Circ J. 2018. PMID: 29445059
• Fontan-associated Liver Disease.
  Téllez L, Rodríguez de Santiago E, Albillos A. Téllez L, et al. Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):192-202. doi: 10.1016/j.rec.2017.10.052. Epub 2018 Feb 9. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29433942 Review. English, Spanish.
• Understanding Fontan-Associated Liver Disease-The Role of Tools for Noninvasive Assessment.
  Partington SL. Partington SL. World J Pediatr Congenit Heart Surg. 2020 Sep;11(5):578. doi: 10.1177/2150135120945973. World J Pediatr Congenit Heart Surg. 2020. PMID: 32853071 Review. No abstract available.

Cited by

• From Fragmented Data to Actionable Insights: Predicting HCC in Fontan Patients-A Call for Collaboration.
  Hilscher M, Venkatesh S. Hilscher M, et al. Dig Dis Sci. 2024 Oct 28. doi: 10.1007/s10620-024-08678-1. Online ahead of print. Dig Dis Sci. 2024. PMID: 39466492 No abstract available.
• Prognostic Indicators of Morbidity and Mortality in Children with Congestive Hepatopathy Presenting with Ascites.
  Spahic H, Wasuwanich P, Modanloo B, Rajborirug S, Kutty S, Cedars A, Karnsakul W. Spahic H, et al. Diagnostics (Basel). 2024 Jul 26;14(15):1618. doi: 10.3390/diagnostics14151618. Diagnostics (Basel). 2024. PMID: 39125494 Free PMC article.
• Histopathological Spectrum and Molecular Characterization of Liver Tumors in the Setting of Fontan-Associated Liver Disease.
  Francalanci P, Giovannoni I, Tancredi C, Gagliardi MG, Palmieri R, Brancaccio G, Spada M, Maggiore G, Pietrobattista A, Monti L, Castellano A, Giustiniani MC, Onetti Muda A, Alaggio R. Francalanci P, et al. Cancers (Basel). 2024 Jan 11;16(2):307. doi: 10.3390/cancers16020307. Cancers (Basel). 2024. PMID: 38254797 Free PMC article.
• The potential of cardiac xenotransplantation for management of infants with complex congenital heart disease.
  Cleveland JD, Mitchell C, Cooper DKC, Cleveland DC. Cleveland JD, et al. Transl Pediatr. 2023 Dec 26;12(12):2247-2255. doi: 10.21037/tp-22-664. Epub 2023 Dec 22. Transl Pediatr. 2023. PMID: 38197100 Free PMC article. Review.
• Liver Biopsy Leads to Serendipitous Diagnosis of Glycogen Storage Disease Type IX in a Patient With Fontan-Associated Liver Disease.
  Hyer E, Alexander C, Rand EB, Diamond T. Hyer E, et al. JPGN Rep. 2023 Oct 31;4(4):e377. doi: 10.1097/PG9.0000000000000377. eCollection 2023 Nov. JPGN Rep. 2023. PMID: 38034453 Free PMC article.

References

1. 1. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, et al. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33(7):1001–12.
2. 1. Johnson JA, Cetta F, Graham RP, Smyrk TC, Driscoll DJ, Phillips SD, et al. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J Thorac Cardiovasc Surg. 2013;146(1):140–5.
3. 1. Greenway SC, Crossland DS, Hudson M, Martin SR, Myers RP, Prieur T, et al. Fontan‐associated liver disease: implications for heart transplantation. J Heart Lung Transplant. 2016;35(1):26–33.
4. 1. Wu FM, Earing MG, Aboulhosn JA, Johncilla ME, Singh MN, Odze RD, et al. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J Heart Lung Transplant. 2017;36(2):211–9.
5. 1. Wu FM, Kogon B, Earing MG, Aboulhosn JA, Broberg CS, John AS, et al. Liver health in adults with Fontan circulation: a multicenter cross‐sectional study. J Thorac Cardiovasc Surg. 2017;153(3):656–64.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley
  • Wolters Kluwer

• Other Literature Sources

  • H1 Connect

• Medical

  • MedlinePlus Health Information